Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

Details for Australian Patent Application No. 2010324506 (hide)

Owner National Research Council of Canada Alethia Biotherapeutics Inc.

Inventors Tremblay, Gilles Bernard; Filion, Mario; Sulea, Traian

Agent FB Rice

Pub. Number AU-A-2010324506

PCT Pub. Number WO2011/063523

Priority 61/263,865 24.11.09 US

Filing date 24 November 2010

Wipo publication date 3 June 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/063523 Priority application(s): WO2011/063523

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324508-Novel emulsified release agent for composite panel

2010324501-Density based clustering for multidimensional data